Company OverviewGBS Inc
GBS Inc. is on a mission to put the power of non-invasive, real-time diagnostic testing in the hands of patients and their primary health practitioners at point of care. With the world-first Biosensor Platform, GBS Inc. is developing and launching diagnostic tests urgently needed to help eradicate COVID-19 and change the lives of people living with diabetes. GBS Inc. is a member of The iQ Group Global, an award-winning consortium of companies that finds, funds and develops innovative bioscience intellectual property from world-class academic institutions to create life-changing medical innovations. What starts here changes the world.
Speaker BioCEO, President, & Director
GBS Inc.
Mr. Simeonidis has more than 25 years’ experience in global executive management positions in healthcare, pharmaceutical and life sciences businesses. His previous roles include CEO of Australia and New Zealand at GE Healthcare and, more recently, General Manager for Surgery Asia Pacific at GE Healthcare. Mr Simeonidis also serves as Non-Executive Director of FarmaForce, a member company of The iQ Group Global.
